Biotech · Private company
ImmVira Pharma Co. Ltd
Track this companyFree. Adds ImmVira Pharma Co. Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- T3011Phase 2 · Nonmuscle-invasive Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- T3011Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- T3011 + CobimetinibPhase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- T3011 + pembrolizumabPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- C5252Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBCPHASE2 · RECRUITING · started Jun 9, 2025ClinicalTrials.gov NCT06971614 · fetched Nov 12, 2026
- T3011 in Combination With Cobimetinib in Patients With Advanced MelanomaPHASE2 · SUSPENDED · started Jun 30, 2024ClinicalTrials.gov NCT05756556 · fetched Nov 12, 2026
- A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive GlioblastomaPHASE1 · UNKNOWN · started Mar 15, 2023ClinicalTrials.gov NCT05095441 · fetched Nov 12, 2026
- Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid TumorsPHASE1_PHASE2 · UNKNOWN · started Aug 10, 2021ClinicalTrials.gov NCT04780217 · fetched Nov 12, 2026
- A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started Sep 17, 2020ClinicalTrials.gov NCT04370587 · fetched Nov 12, 2026